TY  - GEN
AU  - Quarta, C Cristina
AU  - Fontana, Marianna
AU  - Damy, Thibaud
AU  - Catini, Julia
AU  - Simoneau, Damien
AU  - Mercuri, Michele
AU  - Garcia-Pavia, Pablo
AU  - Maurer, Mathew S
AU  - Palladini, Giovanni
PY  - 2022
DO  - 10.3389/fcvm.2022.1073503
SN  - 2297-055X
UR  - http://hdl.handle.net/20.500.12105/16556
AB  - Cardiac amyloidosis is a rare, debilitating, and usually fatal disease increasingly recognized in clinical practice despite patients presenting with non-specific symptoms of cardiomyopathy. The current standard of care (SoC) focuses on preventing...
LA  - eng
PB  - Frontiers Media
TI  - Changing paradigm in the treatment of amyloidosis: From disease-modifying drugs to anti-fibril therapy.
TY  - review
ER  -